世界のOTC医薬品市場2020-2027:新型コロナの影響、製品タイプ別(咳、風邪、インフルエンザ製品、鎮痛剤、皮膚科製品、胃腸製品、ビタミン、ミネラル、サプリメント(VMS)、減量/食事療法製品、その他)、流通チャンネル別、地域別

◆英語タイトル:Global Over the Counter (OTC) Drugs Market Size study with COVID-19 impact, by Product Type (Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight-loss/Dietary Products, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Others) and Regional Forecasts 2020-2027
◆商品コード:BZW20JL068
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年6月25日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、英国、ドイツ、フランス、中国、インド、日本、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥656,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、OTC医薬品の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、市場分析、製品タイプ別(咳、風邪、インフルエンザ製品、鎮痛剤、皮膚科製品、胃腸製品、ビタミン、ミネラル、サプリメント(VMS))分析、流通チャンネル別分析、地域別分析、競争状況、調査プロセスなどを含め、以下の構成でご提供いたします。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・市場分析
・OTC医薬品の世界市場規模:製品タイプ別(咳、風邪、インフルエンザ製品、鎮痛剤、皮膚科製品、胃腸製品、ビタミン、ミネラル、サプリメント(VMS))
・OTC医薬品の世界市場規模:流通チャンネル別
・OTC医薬品の世界市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Over the Counter (OTC) Drugs Market is valued approximately USD 266 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 6% over the forecast period 2020-2027. Over the Counter (OTC) drugs are also referred as non-prescription medicines, as these can be bought without doctor’s prescriptions. OTC drugs are safe if they are dispensed as per the instructions given by healthcare professionals. OTC drugs are normally regulated according to their active pharmaceutical ingredient (API) instead of final products. By regulating APIs rather than specific drug formulations, government bodies allow manufacturers the autonomy to formulate ingredients, or mixtures of materials, into proprietary combinations. Also, it contains non-nutrient chemicals, which offers biological benefit to the body. Further, the demand for disinfectant products is remarkably growing, as a preventive measure for COVID-19, which has resulted in the rise in demand for OTC drugs & painkillers. That is the short-term impact to market growth. As the production of OTC drugs is less significant due to the lockdown in various countries. Thus, it has forced the companies to develop the post-COVID strategies to avoid decline and promote market growth in the near future. Increasing consumption of dietary supplements, improvement in lifestyle and age-related diseases and growing awareness regarding general health concerns are the few factors responsible for high CAGR of the market over the forecast period. For instance, according to Council for Responsible Nutrition, the U.S.-based trade association, about 76% of Americans of all of all ages are using dietary supplements, an increase of around 64% from 2008. Among all ages, the adults aged 55 & above consume the dietary supplements most, which is about 80% in 2017 increased from 74% since 2016. This, in turn, is expected to accelerate the demand for Over the Counter (OTC) Drugs, thus contributing to the growth of the global market. However, stringent regulatory policies by governing bodies and lack of seamless reclassification of drugs are the few factors expected to hamper the growth of the market over the forecast period of 2020-2027.

The regional analysis of global Over the Counter (OTC) Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the trend among pharmaceutical companies to switch from Rx to OTC drugs and increasing consumption of dietary supplements in the region. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027, due to growing awareness among individuals about the use of OTC drugs to cure minor health issues, especially in China and India.

Major market player included in this report are:
Johnson and Johnson
Novartis AG
Bayer AG
Sanofi
Pfizer
GlaxoSmithKline PLC
Perrigo Company PLC
Reckitt Benckiser Group PLC
Takeda Pharmaceutical Company Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Cough, Cold, and Flu Products
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Mineral, and Supplements (VMS)
Weight-loss/Dietary Products
Others

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Over the Counter (OTC) Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Over the Counter (OTC) Drugs Market, by Region, 2018-2027 (USD Billion)
1.2.2. Over the Counter (OTC) Drugs Market, by Product Type, 2018-2027 (USD Billion)
1.2.3. Over the Counter (OTC) Drugs Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Over the Counter (OTC) Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Over the Counter (OTC) Drugs Market Dynamics
3.1. Over the Counter (OTC) Drugs Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Over the Counter (OTC) Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Over the Counter (OTC) Drugs Market, by Product Type
5.1. Market Snapshot
5.2. Global Over the Counter (OTC) Drugs Market by Product Type, Performance – Potential Analysis
5.3. Global Over the Counter (OTC) Drugs Market Estimates & Forecasts by Product Type 2017-2027 (USD Billion)
5.4. Over the Counter (OTC) Drugs Market, Sub Segment Analysis
5.4.1. Cough, Cold, and Flu Products
5.4.2. Analgesics
5.4.3. Dermatology Products
5.4.4. Gastrointestinal Products
5.4.5. Vitamins, Mineral, and Supplements (VMS)
5.4.6. Weight-loss/Dietary Products
5.4.7. Others
Chapter 6. Global Over the Counter (OTC) Drugs Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Over the Counter (OTC) Drugs Market by Distribution Channel, Performance – Potential Analysis
6.3. Global Over the Counter (OTC) Drugs Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Billion)
6.4. Over the Counter (OTC) Drugs Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacy
6.4.4. Others
Chapter 7. Global Over the Counter (OTC) Drugs Market, Regional Analysis
7.1. Over the Counter (OTC) Drugs Market, Regional Market Snapshot
7.2. North America Over the Counter (OTC) Drugs Market
7.2.1. U.S. Over the Counter (OTC) Drugs Market
7.2.1.1. Product Type breakdown estimates & forecasts, 2017-2027
7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Over the Counter (OTC) Drugs Market
7.3. Europe Over the Counter (OTC) Drugs Market Snapshot
7.3.1. U.K. Over the Counter (OTC) Drugs Market
7.3.2. Germany Over the Counter (OTC) Drugs Market
7.3.3. Rest of Europe Over the Counter (OTC) Drugs Market
7.4. Asia-Pacific Over the Counter (OTC) Drugs Market Snapshot
7.4.1. China Over the Counter (OTC) Drugs Market
7.4.2. India Over the Counter (OTC) Drugs Market
7.4.3. Japan Over the Counter (OTC) Drugs Market
7.4.4. Rest of Asia Pacific Over the Counter (OTC) Drugs Market
7.5. Latin America Over the Counter (OTC) Drugs Market Snapshot
7.5.1. Brazil Over the Counter (OTC) Drugs Market
7.5.2. Mexico Over the Counter (OTC) Drugs Market
7.6. Rest of The World Over the Counter (OTC) Drugs Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Johnson and Johnson
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Novartis AG
8.2.3. Bayer AG
8.2.4. Sanofi S.A.
8.2.5. Pfizer Inc.
8.2.6. GlaxoSmithKline PLC
8.2.7. Perrigo Company PLC
8.2.8. Reckitt Benckiser Group PLC
8.2.9. Takeda Pharmaceutical Company Ltd.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

TABLE 1. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, REPORT SCOPE
TABLE 2. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
TABLE 3. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY PRODUCT TYPE 2017-2027 (USD BILLION)
TABLE 4. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2017-2027 (USD BILLION)
TABLE 5. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 6. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 7. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 8. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 9. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 10. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 11. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 12. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 13. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 14. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 15. U.S. OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 16. U.S. OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 17. U.S. OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 18. CANADA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 19. CANADA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 20. CANADA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 21. UK OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 22. UK OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 23. UK OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 24. GERMANY OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 25. GERMANY OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 26. GERMANY OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 27. ROE OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 28. ROE OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 29. ROE OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 30. CHINA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 31. CHINA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 32. CHINA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 33. INDIA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 34. INDIA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 35. INDIA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 36. JAPAN OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 37. JAPAN OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 38. JAPAN OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 39. ROAPAC OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 40. ROAPAC OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 41. ROAPAC OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 42. BRAZIL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 43. BRAZIL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 44. BRAZIL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 45. MEXICO OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 46. MEXICO OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 47. MEXICO OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 48. ROLA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 49. ROLA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 50. ROLA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 51. ROW OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 52. ROW OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 53. ROW OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 54. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET
TABLE 55. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET
TABLE 56. YEARS CONSIDERED FOR THE STUDY
TABLE 57. EXCHANGE RATES CONSIDERED

FIG 1. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, GROWTH PROSPECTS 2020-2027
FIG 6. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, PEST ANALYSIS
FIG 8. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 10. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 11. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 12. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 13. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 14. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, REGIONAL SNAPSHOT 2017 & 2027
FIG 15. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 16. EUROPE OVER THE COUNTER (OTC) DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 17. ASIA PACIFIC OVER THE COUNTER (OTC) DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 18. LATIN AMERICA OVER THE COUNTER (OTC) DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 19. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のOTC医薬品市場2020-2027:新型コロナの影響、製品タイプ別(咳、風邪、インフルエンザ製品、鎮痛剤、皮膚科製品、胃腸製品、ビタミン、ミネラル、サプリメント(VMS)、減量/食事療法製品、その他)、流通チャンネル別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆